Victory Capital Management’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-37,286
Closed -$537K 2479
2025
Q4
$537K Buy
+37,286
New +$465K ﹤0.01% 2000
2023
Q2
Sell
-10,768
Closed -$204K 2583
2023
Q1
$204K Sell
10,768
-6,753
-39% -$149K ﹤0.01% 2243
2022
Q4
$397K Sell
17,521
-15,231
-47% -$344K ﹤0.01% 2085
2022
Q3
$866K Buy
32,752
+8,536
+35% +$253K ﹤0.01% 1801
2022
Q2
$598K Buy
24,216
+9,992
+70% +$250K ﹤0.01% 1971
2022
Q1
$395K Buy
+14,224
New +$395K ﹤0.01% 2213
2021
Q4
Sell
-4,794
Closed -$201K 2834
2021
Q3
$201K Buy
+4,794
New +$172K ﹤0.01% 2526
2020
Q2
Sell
-9,392
Closed -$304K 3120
2020
Q1
$304K Buy
9,392
+3,823
+69% +$159K ﹤0.01% 2233
2019
Q4
$228K Buy
5,569
+687
+14% +$27.1K ﹤0.01% 2278
2019
Q3
$174K Sell
4,882
-36,377
-88% -$1.47M ﹤0.01% 2263
2019
Q2
$2.12M Sell
41,259
-2,620
-6% -$131K ﹤0.01% 1128
2019
Q1
$2.52M Sell
43,879
-490
-1% -$24.3K 0.01% 1041
2018
Q4
$1.86M Buy
44,369
+9,510
+27% +$558K ﹤0.01% 1056
2018
Q3
$2.63M Sell
34,859
-28,750
-45% -$2.07M 0.01% 1045
2018
Q2
$4.56M Sell
63,609
-3,550
-5% -$170K 0.01% 863
2018
Q1
$2M Buy
67,159
+7,330
+12% +$213K ﹤0.01% 1069
2017
Q4
$1.99M Buy
59,829
+11,300
+23% +$340K ﹤0.01% 1038
2017
Q3
$1.6M Buy
48,529
+2,070
+4% +$46.6K ﹤0.01% 1082
2017
Q2
$918K Sell
46,459
-510
-1% -$9.88K ﹤0.01% 1207
2017
Q1
$907K Buy
46,969
+11,079
+31% +$214K ﹤0.01% 1200
2016
Q4
$666K Sell
35,890
-12,960
-27% -$248K ﹤0.01% 1223
2016
Q3
$684K Buy
+48,850
New +$539K ﹤0.01% 1158

Other funds holding RGNX